Thick pancreas, dense duct branching, and limited fibrosis as risk factors for pancreatic fistula after distal pancreatectomy Authors: Toshiyuki Suzuki, Motokazu Sugimoto, Motohiro Kojima, Masashi Kudo, Shin Kobayashi, Genichiro Ishii, Naoto Gotohda Published: 2026 ABSTRACT BackgroundThe reported incidence of clinically-relevant postoperative pancreatic fistula (CR-POPF) after distal pancreatectomy (DP) ranges from 10% to 40%. Identification of risk factors for POPF may enable individualized modification of surgical techniques and postoperative management strategies. This study aimed to elucidate the clinico-histopathological characteristics associated with CR-POPF after DP.MethodsA total of 186 patients who underwent DP were investigated. Pancreatic thickness at the planned transection site was measured using preoperative computed tomography. Histopathological findings of the pancreatic stump, including branched pancreatic duct (BPD) density and fibrosis ratio, were assessed quantitatively using morphometric analysis. Risk factors for CR-POPF were analyzed.ResultsThe incidence of CR-POPF was 33%. Factors associated with CR-POPF included pancreatic thickness ≥ 11.7 mm (odds ratio [OR] 3.736; p < 0.001), BPD density ≥ 2.5/100 mm² (OR 5.173; p < 0.001), and fibrosis ratio < 4.4% (OR 2.596; p = 0.041). Patients with pancreatic thickness ≥ 11.7 mm showed higher BPD density (2.5 vs. 1.8/100 mm²; p = 0.002) and lower fibrosis ratio (3.2% vs. 3.6%; p = 0.022).ConclusionGreater pancreatic thickness, higher BPD density, and lower fibrosis ratio at the transection site were associated with CR-POPF after DP. As high BPD density and low fibrosis ratio were also associated with increased pancreatic thickness, these findings suggest that anatomical and histopathological pancreatic features may be jointly related to the risk of CR-POPF.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12876-026-05020-z. Introduction The incidence of clinically-relevant postoperative pancreatic fistula (CR-POPF) after distal pancreatectomy (DP) has been reported to range from 10% to 40% [1–4]. POPF can lead to serious complications, including intra-abdominal abscess, sepsis, and hemorrhage from ruptured pseudoaneurysms, some of which may be life-threatening. Identifying high-risk patients before or during surgery may allow for tailored surgical techniques and perioperative management, potentially improving postoperative outcomes. However, no definitive strategy to prevent CR-POPF has yet been established. In pancreatic surgery, surgeons typically assess the pancreatic texture intraoperatively by visual inspection and palpation, classifying it subjectively as “soft” or “hard”. A soft pancreas generally represents a normal gland with abundant lobular tissue and preserved exocrine function, whereas a hard pancreas reflects fibrosis or chronic inflammatory changes. A soft pancreatic texture is a well-established risk factor for CR-POPF, particularly after pancreaticoduodenectomy (PD) [5–8]. However, in patients undergoing DP, where lesions are located in the pancreatic body or tail, the transection site is usually on the pancreatic head side of the lesion. Even when tumors obstruct the main pancreatic duct (MPD) and induce inflammation or fibrosis toward the tail side, the pancreatic texture at the transection site often remains soft [5, 8–10]. Several studies in PD, including our own, have demonstrated that limited fibrosis or fatty infiltration of the pancreas is associated with CR-POPF [5, 8, 11–13]. In contrast, in DP, the pancreatic texture at the transection site is generally soft across most cases, making it difficult to distinguish subtle histopathological differences using visual or tactile assessment alone. Consequently, studies examining the relationship between detailed histopathological features of the pancreatic stump and CR-POPF after DP are limited. Therefore, the present study aimed to identify risk factors for CR-POPF after DP by incorporating quantitative morphometric analysis of histopathological findings at the pancreatic transection stump. Methods Patients and clinical data collection A total of 224 patients underwent DP at the National Cancer Center Hospital East between January 2012 and December 2019. Of these, 27 patients were excluded due to the unavailability of pancreatic stump specimens for morphometric analysis, and an additional 11 patients were excluded because surgery was performed for malignancies originating from adjacent organs (stomach, n = 9; ovary, n = 1; kidney, n = 1). The remaining 186 patients were included in the analysis. Clinicopathological data were retrospectively collected from electronic medical records. This study was approved by the Institutional Review Board of the National Cancer Center (approval number: 2016 − 193), and the requirement for informed consent was waived due to the retrospective nature of the study. Surgical procedure and perioperative management DP was performed using standardized operative techniques and perioperative management protocols, as previously described [14, 15]. The splenic artery and vein were ligated and divided prior to pancreatic transection, and lymph node dissection was performed when indicated. Pancreatic texture at the planned transection site was assessed intraoperatively by an experienced pancreatic surgeon and classified as either soft or hard. Pancreatic transection was performed using one of the following devices, at the surgeon’s discretion: a triple-row stapler (Powered Echelon Flex 60 mm [Ethicon, Somerville, NJ, USA] or Endo-GIA Ultra Tri-Staple/iDrive Ultra Powered Stapling System [Medtronic, Minneapolis, MN, USA]), or laparoscopic coagulating shears (LCS; HARMONIC, Ethicon Endo-Surgery, Cincinnati, OH, USA). When LCS was used, the pancreatic parenchyma was sealed and divided while carefully identifying the MPD, which was then transected using a knife and subsequently ligated or sutured. Intraoperative frozen section analysis of the pancreatic stump was routinely performed to confirm the absence of malignancy, with additional resection performed as necessary. A closed-suction drain was placed adjacent to the pancreatic stump. Drain amylase levels and bacterial cultures were evaluated on postoperative days 1, 3, and 5. Drains were typically removed between postoperative days 3 and 5 in the absence of persistent amylase-rich fluid or signs of infection. Somatostatin analogues were not administered perioperatively. CR-POPF was defined as grade B or C according to the 2016 International Study Group on Pancreatic Surgery criteria [16]. Schema of the pancreatic stump The anatomical configuration of the pancreatic stump was evaluated as previously described [8, 14, 15, 17] The pancreatic stump was modeled as an ellipse, and the MPD as a circle (Fig. 1a). Pancreatic thickness and MPD diameter at the transection site were measured using 2-mm-slice preoperative computed tomography (CT) images (Fig. 1b). The transection site was identified based on its anatomical relationship with major vascular structures, such as the portal vein/superior mesenteric vein or the superior mesenteric artery, as documented intraoperatively or determined by comparing pre- and postoperative CT images. Fig. 1a. Schematic illustration of the pancreatic transection stump. The pancreatic stump is represented as an ellipse and the main pancreatic duct (MPD) as a circle b. Pancreatic thickness and MPD diameter at the transection site were measured using axial 2-mm preoperative computed tomography images. Pancreatic thickness (large arrow) and MPD diameter (small arrow) were assessed at the level of the planned transection. The transection site was identified based on its anatomical relationship with surrounding structures, including the superior mesenteric vein (#) and superior mesenteric artery (*) a. Schematic illustration of the pancreatic transection stump. The pancreatic stump is represented as an ellipse and the main pancreatic duct (MPD) as a circle b. Pancreatic thickness and MPD diameter at the transection site were measured using axial 2-mm preoperative computed tomography images. Pancreatic thickness (large arrow) and MPD diameter (small arrow) were assessed at the level of the planned transection. The transection site was identified based on its anatomical relationship with surrounding structures, including the superior mesenteric vein (#) and superior mesenteric artery (*) Morphometric analysis of the pancreatic stump Pancreatic stump specimens were formalin-fixed and paraffin-embedded. Serial sections of 3-µm thickness were prepared and stained with hematoxylin and eosin (H&E) and Azan-Mallory (azan). Digital images were obtained using the NanoZoomer virtual slide system (Hamamatsu Photonics, Hamamatsu, Japan), and morphometric analysis was performed as previously described [5, 8, 12]. Using H&E-stained images, the areas of the entire cut surface, MPD, and branched pancreatic ducts (BPDs) were quantified. Fibrosis was assessed using azan-stained images. All measurements were performed using WinROOF version 6.5 (Mitani Corporation, Tokyo, Japan). BPDs with a major axis ≥ 0.2 mm were counted, and adjacent ducts were regarded as a single BPD. Histopathological parameters were defined as follows: total area: area within the outer circumference, lobular area: H&E-positive area – azan-positive area, fat area: total area – (H&E-positive area + MPD area), MPD ratio: (MPD area / total area) × 100, BPD density: number of BPDs / (total area – MPD area) × 100, lobular ratio: (lobular area / [total area – MPD area]) × 100, fibrosis ratio: (azan-positive area / [total area – MPD area]) × 100, fat ratio: (fat area / [total area − MPD area]) × 100. The procedures for morphometric analysis are illustrated in Figs. 2 and 3. All analyses were conducted by a single investigator (T.S.) under the supervision of an experienced pathologist (M.K.). Fig. 2 Histopathological findings (loupe images) of a patient who underwent distal pancreatectomy for pancreatic ductal adenocarcinoma and developed grade B postoperative pancreatic fistula a. Hematoxylin and eosin (H&E)-stained section. The inset shows the MPD. The outer border of the entire cut surface (blue line) and the inner border of the MPD lumen (red line) were manually outlined, and the corresponding areas were calculated using WinROOF software (version 6.5; Mitani Corporation, Tokyo, Japan) b. H&E-positive areas were detected using a color-based algorithm (represented as yellow-green). The fat area measured 51.2 mm², with a fat ratio of 19.1% c. Azan-Mallory-stained section d. Fibrosis area (yellow-green) was quantified using a color-detection algorithm. The fibrosis area was 4.4 mm² (fibrosis ratio, 1.7%). The lobular area was 212.1 mm² (lobular ratio, 79.2%) e. H&E-stained image showing a magnified view of a branched pancreatic duct (BPD). Nine BPDs ≥ 0.2 mm were identified, yielding a BPD density of 3.4/100 mm² Histopathological findings (loupe images) of a patient who underwent distal pancreatectomy for pancreatic ductal adenocarcinoma and developed grade B postoperative pancreatic fistula a. Hematoxylin and eosin (H&E)-stained section. The inset shows the MPD. The outer border of the entire cut surface (blue line) and the inner border of the MPD lumen (red line) were manually outlined, and the corresponding areas were calculated using WinROOF software (version 6.5; Mitani Corporation, Tokyo, Japan) b. H&E-positive areas were detected using a color-based algorithm (represented as yellow-green). The fat area measured 51.2 mm², with a fat ratio of 19.1% c. Azan-Mallory-stained section d. Fibrosis area (yellow-green) was quantified using a color-detection algorithm. The fibrosis area was 4.4 mm² (fibrosis ratio, 1.7%). The lobular area was 212.1 mm² (lobular ratio, 79.2%) e. H&E-stained image showing a magnified view of a branched pancreatic duct (BPD). Nine BPDs ≥ 0.2 mm were identified, yielding a BPD density of 3.4/100 mm² Fig. 3Histopathological findings (loupe images) of a patient who underwent distal pancreatectomy for pancreatic ductal adenocarcinoma and did not develop postoperative pancreatic fistula a. H&E-stained section. The area of the entire cut surface was 124.4 mm², and the MPD area was 0.74 mm² b. The fat area was 30.0 mm², with a fat ratio of 24.3% c. Azan-Mallory-stained section d. The fibrosis area was 6.1 mm² (fibrosis ratio, 4.9%). The lobular area was 87.6 mm² (lobular ratio, 70.8%) e. Three BPDs ≥ 0.2 mm were identified, corresponding to a BPD density of 2.4/100 mm² Histopathological findings (loupe images) of a patient who underwent distal pancreatectomy for pancreatic ductal adenocarcinoma and did not develop postoperative pancreatic fistula a. H&E-stained section. The area of the entire cut surface was 124.4 mm², and the MPD area was 0.74 mm² b. The fat area was 30.0 mm², with a fat ratio of 24.3% c. Azan-Mallory-stained section d. The fibrosis area was 6.1 mm² (fibrosis ratio, 4.9%). The lobular area was 87.6 mm² (lobular ratio, 70.8%) e. Three BPDs ≥ 0.2 mm were identified, corresponding to a BPD density of 2.4/100 mm² Statistical analysis Clinical variables, CT findings, intraoperative parameters, and histopathological characteristics of the pancreatic stump were compared between patients with and without CR-POPF. Categorical variables were compared using the chi-square test and are presented as counts and percentages. Continuous variables were compared using the Mann–Whitney U-test and are expressed as medians with interquartile ranges. Univariable and multivariable logistic regression analyses were performed to identify risk factors for CR-POPF. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Variables that were significant in the univariable analysis were dichotomized based on cut-off values determined by receiver operating characteristic (ROC) curve analysis and subsequently included in the multivariable model. Correlations between variables were assessed using Spearman’s rank correlation coefficient (r). A two-sided p-value < 0.05 was considered statistically significant. All statistical analyses were performed using JMP version 12 (SAS Institute Inc., Cary, NC, USA). Results Clinico-histopathological characteristics Among the 186 patients included in this study, 61 (33%) developed CR-POPF, all of which were classified as grade B; no grade C POPF occurred. In addition, 63 patients (34%) were categorized as having a biochemical leak (grade A). Table 1 summarizes the clinico-histopathological characteristics of patients with and without CR-POPF. Patients who developed CR-POPF had significantly greater pancreatic thickness at the transection site (13.5 mm vs. 11.0 mm, p < 0.001) and higher intraoperative estimated blood loss (229 mL vs. 141 mL, p = 0.049) than those without CR-POPF. Regarding histopathological findings, patients with CR-POPF had a greater number of BPDs (8 vs. 4, p < 0.001), higher BPD density (3.3/100 mm² vs. 1.5/100 mm², p < 0.001), and lower fibrosis ratio (3.0% vs. 3.7%, p = 0.027) compared with those without CR-POPF. The use of a stapler at pancreatic transection was not significantly different between patients with and without CR-POPF (97% vs. 89%, p = 0.070). Table 1Comparison of clinico-histopathological characteristics between patients with and without CR-POPF after DPVariablesCR-POPF (+)(n = 61)CR-POPF (-)(n = 125)P-valueBackground Age (years)67 [60–71]67 [58–74]0.811 Sex, male32 (52%)63 (50%)0.792 Body mass index (kg/m²)22.6 [21.5–25.3]21.9 [19.9–24.3]0.065 Diabetes19 (31%)37 (30%)0.829 Neoadjuvant therapy14 (23%)22 (18%)0.386 ASA score > 26 (10%)7 (6%)0.287Diagnosis Pancreatic ductal adenocarcinoma42 (69%)70 (56%)0.090 Neuroendocrine tumor7 (12%)15 (12%)0.917 Pancreatic cystic diseases9 (15%)33 (26%)0.075 Others3 (5%)7 (6%)0.847Pancreatic configuration on CT MPD diameter (mm)1.8 [1.4–2.1]1.8 [1.3–2.2]0.893 Pancreatic thickness (mm)13.5 [11.8–15.5]11.0 [9.0-13.3]< 0.001Intraoperative data Minimally-invasive approach23 (38%)58 (46%)0.262 Spleen preservation6 (10%)7 (6%)0.287 Resection of GI tract7 (11%)12 (10%)0.692 Operation time (min)240 [212–280]227 [197–275]0.086 Estimated blood loss (mL)229 [86–479]141 [49–358]0.049 Soft pancreatic texture56 (92%)114 (91%)0.890 Use of stapler at pancreatic transection59 (97%)111 (89%)0.070Histopathological findings Area of an entire cut surface (mm²)259.9 [169.0-355.4]225 [166–351]0.567 Area of MPD (mm²)0.30 [0.11–0.62]0.41 [0.12–1.06]0.113 MPD ratio (%)0.11 [0.04–0.22]0.16 [0.06–0.41]0.062 Number of BPD8 [5–10]4 [2–6]< 0.001 BPD density (/100 mm²)3.3 [1.9–4.3]1.5 [0.7–2.5]< 0.001 Area of lobules (mm²)187.4 [121.3-271.4]167.5 [117.2-279.5]0.338 Lobular ratio (%)78.1 [72.8–85.4]75.3 [67.4–83.1]0.123 Area of fat (mm²)43.6 [24.3–68.5]39.2 [27.3–68.1]0.946 Fat ratio (%)17.6 [11.6–24.2]19.5 [11.6–26.5]0.431 Area of fibrosis (mm²)7.5 [4.2–12.3]8.5 [5.5–13.9]0.086 Fibrosis ratio (%)3.0 [2.4–3.9]3.7 [2.4–5.1]0.027Categorical variables are presented as the numbers and percentages and continuous variables are presented as the median and interquartile rangeAbbreviations ASA American Society of Anesthesiologists, BPD branched pancreatic duct, CR-POPF clinically-relevant postoperative pancreatic fistula, CT computed tomography, DP distal pancreatectomy, GI gastrointestinal, MPD main pancreatic duct. Table 1Comparison of clinico-histopathological characteristics between patients with and without CR-POPF after DPVariablesCR-POPF (+)(n = 61)CR-POPF (-)(n = 125)P-valueBackground Age (years)67 [60–71]67 [58–74]0.811 Sex, male32 (52%)63 (50%)0.792 Body mass index (kg/m²)22.6 [21.5–25.3]21.9 [19.9–24.3]0.065 Diabetes19 (31%)37 (30%)0.829 Neoadjuvant therapy14 (23%)22 (18%)0.386 ASA score > 26 (10%)7 (6%)0.287Diagnosis Pancreatic ductal adenocarcinoma42 (69%)70 (56%)0.090 Neuroendocrine tumor7 (12%)15 (12%)0.917 Pancreatic cystic diseases9 (15%)33 (26%)0.075 Others3 (5%)7 (6%)0.847Pancreatic configuration on CT MPD diameter (mm)1.8 [1.4–2.1]1.8 [1.3–2.2]0.893 Pancreatic thickness (mm)13.5 [11.8–15.5]11.0 [9.0-13.3]< 0.001Intraoperative data Minimally-invasive approach23 (38%)58 (46%)0.262 Spleen preservation6 (10%)7 (6%)0.287 Resection of GI tract7 (11%)12 (10%)0.692 Operation time (min)240 [212–280]227 [197–275]0.086 Estimated blood loss (mL)229 [86–479]141 [49–358]0.049 Soft pancreatic texture56 (92%)114 (91%)0.890 Use of stapler at pancreatic transection59 (97%)111 (89%)0.070Histopathological findings Area of an entire cut surface (mm²)259.9 [169.0-355.4]225 [166–351]0.567 Area of MPD (mm²)0.30 [0.11–0.62]0.41 [0.12–1.06]0.113 MPD ratio (%)0.11 [0.04–0.22]0.16 [0.06–0.41]0.062 Number of BPD8 [5–10]4 [2–6]< 0.001 BPD density (/100 mm²)3.3 [1.9–4.3]1.5 [0.7–2.5]< 0.001 Area of lobules (mm²)187.4 [121.3-271.4]167.5 [117.2-279.5]0.338 Lobular ratio (%)78.1 [72.8–85.4]75.3 [67.4–83.1]0.123 Area of fat (mm²)43.6 [24.3–68.5]39.2 [27.3–68.1]0.946 Fat ratio (%)17.6 [11.6–24.2]19.5 [11.6–26.5]0.431 Area of fibrosis (mm²)7.5 [4.2–12.3]8.5 [5.5–13.9]0.086 Fibrosis ratio (%)3.0 [2.4–3.9]3.7 [2.4–5.1]0.027Categorical variables are presented as the numbers and percentages and continuous variables are presented as the median and interquartile rangeAbbreviations ASA American Society of Anesthesiologists, BPD branched pancreatic duct, CR-POPF clinically-relevant postoperative pancreatic fistula, CT computed tomography, DP distal pancreatectomy, GI gastrointestinal, MPD main pancreatic duct. Comparison of clinico-histopathological characteristics between patients with and without CR-POPF after DP Categorical variables are presented as the numbers and percentages and continuous variables are presented as the median and interquartile range Abbreviations ASA American Society of Anesthesiologists, BPD branched pancreatic duct, CR-POPF clinically-relevant postoperative pancreatic fistula, CT computed tomography, DP distal pancreatectomy, GI gastrointestinal, MPD main pancreatic duct. Risk analysis for CR-POPF Table 2 presents the results of the univariable logistic regression analysis. Significant risk factors for CR-POPF included pancreatic thickness (OR 1.321, p < 0.001), BPD density (OR 1.402, p < 0.001), and fibrosis ratio (OR 0.827, p = 0.004). Although estimated blood loss was significantly different between groups in univariable comparisons, it was not significant in regression analysis. Table 2Univariable risk analysis for CR-POPF after DPVariablesOR95% CIP-valueBackground Age1.0020.976–1.0290.899 Sex (male)1.0860.588–2.0100.792 Body mass index1.0550.966–1.1540.231 Diabetes1.0760.547–2.0770.829 Neoadjuvant therapy1.3940.645–2.9420.390 ASA score > 21.8390.590–5.7290.293Diagnosis Pancreatic ductal adenocarcinoma1.7370.919–3.3660.090 Neuroendocrine tumor0.9510.346–2.3970.910 Pancreatic cystic diseases0.4820.203–1.0500.067Pancreatic configuration on CT MPD diameter1.0160.771–1.2990.905 Pancreatic thickness1.3211.180–1.498< 0.001Intraoperative data Minimally-invasive approach0.6990.374–1.3070.262 Spleen preservation1.8390.590–5.7290.293 Resection of GI tract1.2210.455–3.2750.692 Operation time1.0020.997–1.0060.403 Estimated blood loss1.0000.999–1.0010.277 Soft pancreatic texture1.0900.377–3.5980.878 Use of stapler at pancreatic transection3.7210.818–16.9250.089Histopathological findings Area of an entire cut surface1.0000.998–1.0020.969 MPD ratio0.7190.388–1.0660.111 BPD density1.4021.187–1.684< 0.001 Lobular ratio1.0190.995–1.0460.119 Fat ratio0.9890.965–1.0110.335 Fibrosis ratio0.8270.700-0.9480.004Abbreviations 95% CI 95% confidence interval, ASA American Society of Anesthesiologists, BPD branched pancreatic duct, CR-POPF clinically-relevant postoperative pancreatic fistula, CT computed tomography, DP distal pancreatectomy, GI gastrointestinal, MPD main pancreatic duct, OR odds ratio Table 2Univariable risk analysis for CR-POPF after DPVariablesOR95% CIP-valueBackground Age1.0020.976–1.0290.899 Sex (male)1.0860.588–2.0100.792 Body mass index1.0550.966–1.1540.231 Diabetes1.0760.547–2.0770.829 Neoadjuvant therapy1.3940.645–2.9420.390 ASA score > 21.8390.590–5.7290.293Diagnosis Pancreatic ductal adenocarcinoma1.7370.919–3.3660.090 Neuroendocrine tumor0.9510.346–2.3970.910 Pancreatic cystic diseases0.4820.203–1.0500.067Pancreatic configuration on CT MPD diameter1.0160.771–1.2990.905 Pancreatic thickness1.3211.180–1.498< 0.001Intraoperative data Minimally-invasive approach0.6990.374–1.3070.262 Spleen preservation1.8390.590–5.7290.293 Resection of GI tract1.2210.455–3.2750.692 Operation time1.0020.997–1.0060.403 Estimated blood loss1.0000.999–1.0010.277 Soft pancreatic texture1.0900.377–3.5980.878 Use of stapler at pancreatic transection3.7210.818–16.9250.089Histopathological findings Area of an entire cut surface1.0000.998–1.0020.969 MPD ratio0.7190.388–1.0660.111 BPD density1.4021.187–1.684< 0.001 Lobular ratio1.0190.995–1.0460.119 Fat ratio0.9890.965–1.0110.335 Fibrosis ratio0.8270.700-0.9480.004Abbreviations 95% CI 95% confidence interval, ASA American Society of Anesthesiologists, BPD branched pancreatic duct, CR-POPF clinically-relevant postoperative pancreatic fistula, CT computed tomography, DP distal pancreatectomy, GI gastrointestinal, MPD main pancreatic duct, OR odds ratio Univariable risk analysis for CR-POPF after DP Abbreviations 95% CI 95% confidence interval, ASA American Society of Anesthesiologists, BPD branched pancreatic duct, CR-POPF clinically-relevant postoperative pancreatic fistula, CT computed tomography, DP distal pancreatectomy, GI gastrointestinal, MPD main pancreatic duct, OR odds ratio Cut-off values determined by ROC curve analysis were 11.7 mm for pancreatic thickness (area under the curve [AUC], 0.72), 2.5/100 mm² for BPD density (AUC, 0.75), and 4.4% for fibrosis ratio (AUC, 0.60) (Fig. 4). Diagnostic performance of these cut-off values is shown in Supplemental Table 1. Fig. 4a. Receiver operating characteristic (ROC) curve demonstrating 11.7 mm as the cutoff value for pancreatic thickness associated with clinically-relevant postoperative pancreatic fistula (CR-POPF). The area under the curve (AUC) was 0.72 b. ROC curve identifying BPD density ≥ 2.5/100 mm² as the cutoff predictive of CR-POPF (AUC, 0.75) c. ROC curve showing fibrosis ratio < 4.4% as the optimal cut-off value for predicting CR-POPF (AUC, 0.60) a. Receiver operating characteristic (ROC) curve demonstrating 11.7 mm as the cutoff value for pancreatic thickness associated with clinically-relevant postoperative pancreatic fistula (CR-POPF). The area under the curve (AUC) was 0.72 b. ROC curve identifying BPD density ≥ 2.5/100 mm² as the cutoff predictive of CR-POPF (AUC, 0.75) c. ROC curve showing fibrosis ratio < 4.4% as the optimal cut-off value for predicting CR-POPF (AUC, 0.60) Correlation coefficients among histopathological variables are presented in Supplemental Table 2. A strong negative correlation was observed between fat ratio and lobular ratio (r = − 0.951, p < 0.001), whereas no significant correlation was found between BPD density and fibrosis ratio (r = − 0.100, p = 0.175). Multivariable analysis incorporating these cutoff values identified the following risk factors for CR-POPF (Table 3): pancreatic thickness ≥ 11.7 mm (OR 3.736; 95% CI 1.769–8.262; p < 0.001), BPD density ≥ 2.5/100 mm² (OR 5.173; 95% CI 2.557–10.794; p < 0.001), and fibrosis ratio < 4.4% (OR 2.596; 95% CI 1.040–7.190; p = 0.041). The incidence of CR-POPF was significantly higher in patients with pancreatic thickness ≥ 11.7 mm than in those < 11.7 mm (48% vs. 15%, p < 0.001). Table 3Multivariable risk analysis for CR-POPF after DPVariablesOR95% CIP-valuePancreatic thickness ≥ 11.7 mm3.7361.769–8.262< 0.001BPD density ≥ 2.5 /100 mm²5.1732.557–10.794< 0.001Fibrosis ratio < 4.4%2.5961.040–7.1900.041Abbreviations 95% CI 95% confidence interval, BPD branched pancreatic duct, CR-POPF clinically-relevant postoperative pancreatic fistula, DP distal pancreatectomy, OR odds ratio Table 3Multivariable risk analysis for CR-POPF after DPVariablesOR95% CIP-valuePancreatic thickness ≥ 11.7 mm3.7361.769–8.262< 0.001BPD density ≥ 2.5 /100 mm²5.1732.557–10.794< 0.001Fibrosis ratio < 4.4%2.5961.040–7.1900.041Abbreviations 95% CI 95% confidence interval, BPD branched pancreatic duct, CR-POPF clinically-relevant postoperative pancreatic fistula, DP distal pancreatectomy, OR odds ratio Multivariable risk analysis for CR-POPF after DP Abbreviations 95% CI 95% confidence interval, BPD branched pancreatic duct, CR-POPF clinically-relevant postoperative pancreatic fistula, DP distal pancreatectomy, OR odds ratio Multivariable analysis incorporating pancreatic thickness, BPD density, and fibrosis ratio as continuous variables identified pancreatic thickness (OR 1.301; 95% CI 1.147–1.476; p < 0.001) and BPD density (OR 1.339; 95% CI 1.124–1.595; p = 0.001) as significant risk factors for CR-POPF (Supplemental Table 3). In contrast, fibrosis ratio did not reach statistical significance (OR 0.851; 95% CI 0.721–1.004; p = 0.056). Associations between pancreatic thickness and histopathological findings Table 4 summarizes the histopathological characteristics according to pancreatic thickness category. Patients with pancreatic thickness ≥ 11.7 mm showed higher BPD density (2.5/100 mm² vs. 1.8/100 mm², p = 0.002), lower fibrosis ratio (3.2% vs. 3.6%, p = 0.022), and higher lobular ratio (78.7% vs. 74.1%, p = 0.027) compared with those with pancreatic thickness < 11.7 mm. Table 4Association between pancreatic thickness and histopathological findingsVariablesPancreatic thickness≥ 11.7 mm (n = 101)Pancreatic thickness < 11.7 mm (n = 85)P-valueBPD density (/100 mm²)2.5 [1.3–3.9]1.8 [0.7–2.9]0.002Fibrosis ratio (%)3.2 [2.4–4.1]3.6 [2.8-6.0]0.022Lobular ratio (%)78.7 [72.8–84.2]74.1 [67.3–82.6]0.027Fat ratio (%)17.3 [11.4–24.0]21.2 [12.5–26.5]0.150Continuous variables are presented as the median and interquartile rangeAbbreviations BPD branched pancreatic duct Table 4Association between pancreatic thickness and histopathological findingsVariablesPancreatic thickness≥ 11.7 mm (n = 101)Pancreatic thickness < 11.7 mm (n = 85)P-valueBPD density (/100 mm²)2.5 [1.3–3.9]1.8 [0.7–2.9]0.002Fibrosis ratio (%)3.2 [2.4–4.1]3.6 [2.8-6.0]0.022Lobular ratio (%)78.7 [72.8–84.2]74.1 [67.3–82.6]0.027Fat ratio (%)17.3 [11.4–24.0]21.2 [12.5–26.5]0.150Continuous variables are presented as the median and interquartile rangeAbbreviations BPD branched pancreatic duct Association between pancreatic thickness and histopathological findings Continuous variables are presented as the median and interquartile range Abbreviations BPD branched pancreatic duct Discussion In this study, the incidence of CR-POPF after DP was 33%, consistent with the previously reported incidence of 10–40% [1–4]. Pancreatic thickness ≥ 11.7 mm, BPD density ≥ 2.5/100 mm², and fibrosis ratio < 4.4% were identified as risk factors associated with CR-POPF. Additionally, patients with a thicker pancreas exhibited higher BPD density and lower fibrosis ratio. Among these variables, pancreatic thickness measured by preoperative CT was the only parameter assessable before surgery. Patients with pancreatic thickness ≥ 11.7 mm had a markedly higher incidence of CR-POPF than those with a thinner pancreas (48% vs. 15%, p < 0.001). These findings suggest that preoperative assessment of pancreatic thickness may facilitate early identification of patients at high risk for CR-POPF. Although a thick pancreas has been recognized as a risk factor for CR-POPF after DP [14, 15, 18–21], the underlying structural basis remains incompletely understood. The present study suggests that dense duct branching and limited fibrosis are associated with both increased pancreatic thickness and CR-POPF, and may represent structural characteristics linked to fistula formation. Notably, pancreatic thickness remains the only factor assessable preoperatively and may therefore be the most clinically translatable parameter among the variables evaluated in this study. A stapler is a convenient and widely used tool for pancreatic transection and stump closure during DP; however, it does not completely prevent CR-POPF.4 In a randomized controlled trial, Kawai et al. reported a trend toward a higher incidence of CR-POPF after stapler closure compared with pancreaticojejunostomy in patients with pancreatic thickness > 12 mm, although this difference was not statistically significant (22.2% vs. 6.2%) [21]. Our previous study proposed the “compression index,” defined as stapler height after closure divided by pancreatic thickness, and demonstrated that both pancreatic thickness and a compression index ≤ 0.160 were independent risk factors for CR-POPF after DP [14]. These findings raise the possibility that thicker pancreases may be more susceptible to compression-related parenchymal injury during stapler closure, which could be associated with incomplete sealing of the MPD and/or BPDs and subsequent leakage of pancreatic juice. However, the influence of surgical technique, including device selection and compression conditions, cannot be excluded in the present retrospective analysis. The histopathological findings of the current study are consistent with this interpretation: a thick pancreas was associated with higher BPD density and lower fibrosis ratio. A higher density of BPDs may increase the technical difficulty of achieving complete ductal closure, whereas limited fibrosis may reflect relatively fragile pancreatic parenchyma. These features may therefore be associated with an increased risk of CR-POPF. Thus, in patients with a thick pancreas identified on preoperative CT, careful and atraumatic transection techniques, along with additional measures to ensure adequate closure of BPDs, may help reduce the risk of CR-POPF. Further studies are warranted to optimize surgical strategies and device selection for such patients. In addition, future advances in imaging-based assessment, including radiologic morphometric analysis and radiomics, may enable preoperative estimation of histopathological characteristics, such as BPD density and pancreatic fibrosis, that cannot currently be assessed reliably in the preoperative setting. Such approaches could potentially improve preoperative risk stratification beyond simple measurement of pancreatic thickness and facilitate more individualized surgical planning. Few studies have evaluated histopathological risk factors for CR-POPF specifically in patients undergoing DP. Jutric et al. analyzed 120 patients undergoing DP and found that lower fibrosis grade, thicker pancreas, and higher lobular density were predictors of CR-POPF in recursive partitioning analysis, although no independent risk factors were identified in univariable analysis [22]. Belyaev et al. examined frozen sections from 50 patients undergoing pancreatectomy and reported that low fibrosis grade was a significant risk factor for CR-POPF [23]. Nahm et al. evaluated the proportions of acinar, collagen, and fat components in 294 patients undergoing pancreatectomy and identified a high acinar score as a risk factor for CR-POPF [10]. These earlier studies relied on qualitative and subjective histopathological assessment, whereas the present study employed quantitative morphometric analysis and demonstrated associations of higher BPD density and lower fibrosis ratio with CR-POPF after DP. Surgeons routinely evaluate pancreatic texture intraoperatively; however, the utility of this subjective assessment in predicting CR-POPF after DP remains unclear. Soft pancreatic texture is a well-established risk factor after PD [5–8], but its association with CR-POPF after DP remains inconsistent. One meta-analysis reported no significant association between soft texture and CR-POPF after DP [24], whereas another demonstrated a strong association after PD but found no significant association after DP [25]. The latter study noted that the prevalence of a hard pancreatic texture was 51% in patients undergoing PD and 29% in those undergoing DP. Because pancreatic texture in the present study was consistently assessed at the transection site, a hard pancreas was identified in only 9% of cases. In PD, obstruction of the MPD often induces fibrosis and hardening of the pancreatic body and tail, whereas in DP, the transection site is typically located proximal to the lesion and therefore remains relatively soft. In the present study, the fibrosis ratio did not differ significantly between soft and hard pancreas groups (3.4% vs. 4.0%, p = 0.094) (Supplemental Table 4). In contrast, our previous study in PD demonstrated a significantly higher fibrosis ratio in hard compared with soft pancreases (13.1% vs. 3.0%, p < 0.001) [8]. These findings suggest that fibrotic changes at the DP transection site are generally mild and may not be reliably detected by visual or tactile assessment alone. Accordingly, even subtle histopathological differences, such as the lower fibrosis ratio observed in patients with CR-POPF (3.0% vs. 3.7%, p = 0.027), may be associated with CR-POPF risk despite being clinically inapparent. This study has several limitations. First, it was a single-center retrospective study. However, the sample size of 186 patients is larger than that of previous studies evaluating histopathological factors in DP (32–120 patients) [10, 22, 23]. Second, the analysis assumed that the histopathological features of the resected stump reflect those of the remnant pancreas, which cannot be evaluated directly. This approach has been adopted in prior studies [10, 13, 22, 23], and our morphometric methods have been validated in previous works [5, 8, 12, 17]. Third, although most histopathological features were assessed as area ratios, BPDs were evaluated using density because direct measurement of individual ductal areas is technically challenging. Fourth, the cut-off values for pancreatic thickness, BPD density, and fibrosis ratio were derived from this single-center retrospective cohort and require validation in larger prospective studies. Although analyses using continuous variables yielded broadly consistent results, fibrosis ratio did not retain statistical significance in the continuous-variable multivariable model. Therefore, the findings regarding fibrosis ratio should be interpreted with caution. In addition, the use of ROC-derived cutoffs may have resulted in some loss of information and potential overfitting, as these thresholds were derived within the same cohort without internal or external validation; therefore, external validation in prospective studies is warranted. Fifth, pancreatic thickness, BPD density, and fibrosis ratio are biologically related variables, and although multicollinearity was not statistically significant, some degree of conceptual overlap may remain, potentially leading to overestimation of their independent effects. Sixth, measurements were primarily performed by single investigators using standardized protocols under expert supervision; however, formal interobserver variability was not assessed, which may limit the reproducibility of the findings. Finally, transection and stump closure techniques varied among surgeons. In the present cohort, however, the use of a stapler at pancreatic transection was not significantly associated with CR-POPF. Nevertheless, such technique-related variability may have independently influenced the incidence of CR-POPF regardless of pancreatic morphology. Although the present study aimed to identify pancreas-related structural risk factors rather than technique-dependent variables, the potential confounding effect of surgical technique cannot be excluded. In conclusion, greater pancreatic thickness, higher BPD density, and lower fibrosis ratio were associated with CR-POPF after DP. Among these, pancreatic thickness is the only variable assessable preoperatively and may therefore be the most clinically applicable parameter for risk stratification. A thick pancreas was characterized by dense duct branching and limited fibrosis, which may be associated with incomplete closure of pancreatic ducts and increased susceptibility of the pancreatic stump to injury. These findings provide insight into pancreatic structural characteristics that may be associated with the development of CR-POPF after DP, although further external validation is warranted. Supplementary Information Supplementary Material 1. Supplementary Material 1.